Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Glauser

Showing results (161-170 of 243) with videos related to

Pageof 25
Sort By:
Schweizerische Medizinische Wochenschrift|March 4, 1995
[Should patients over 65 years old with acute myeloid leukemia be treated with myelosuppressive chemotherapy?]V Spataro, A Cometta, M P Glauser, et al.
The Journal of Infectious Diseases|January 1, 1997
Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordoniiJ M Entenza, I Caldelari, M P Glauser, et al.
Critical Care Medicine|September 1, 1996
International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committeeC L Sprung, R G Finch, L G Thijs, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1992
Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in ratsJ M Entenza, T Calandra, Y Moosmann, et al.
Infection and Immunity|June 24, 2003
Teichoic acids are not required for Streptococcus pneumoniae and Staphylococcus aureus cell walls to trigger the release of tumor necrosis factor by peripheral blood monocytesP A Majcherczyk, E Rubli, D Heumann, et al.
The American Journal of Medicine|July 1, 1991
High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study GroupT Calandra, J Gerain, D Heumann, et al.
Schweizerische Medizinische Wochenschrift|September 9, 1989
[Candida fungemia]G Zanetti, T Calandra, B de Muralt, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1986
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patientsJ Klastersky, M P Glauser, S C Schimpff, et al.
Lancet (London, England)|February 27, 1988
Post-exposure prophylaxis against HIV infection in health care workersP R Meylan, P Francioli, H Decrey, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistanceJ M Entenza, Y A Que, J Vouillamoz, et al.
Pageof 25

Showing results (161-170 of 243) with videos related to

Sort By:
Pageof 25
Schweizerische Medizinische Wochenschrift|March 4, 1995
[Should patients over 65 years old with acute myeloid leukemia be treated with myelosuppressive chemotherapy?]V Spataro, A Cometta, M P Glauser, et al.
The Journal of Infectious Diseases|January 1, 1997
Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordoniiJ M Entenza, I Caldelari, M P Glauser, et al.
Critical Care Medicine|September 1, 1996
International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committeeC L Sprung, R G Finch, L G Thijs, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1992
Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in ratsJ M Entenza, T Calandra, Y Moosmann, et al.
Infection and Immunity|June 24, 2003
Teichoic acids are not required for Streptococcus pneumoniae and Staphylococcus aureus cell walls to trigger the release of tumor necrosis factor by peripheral blood monocytesP A Majcherczyk, E Rubli, D Heumann, et al.
The American Journal of Medicine|July 1, 1991
High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study GroupT Calandra, J Gerain, D Heumann, et al.
Schweizerische Medizinische Wochenschrift|September 9, 1989
[Candida fungemia]G Zanetti, T Calandra, B de Muralt, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1986
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patientsJ Klastersky, M P Glauser, S C Schimpff, et al.
Lancet (London, England)|February 27, 1988
Post-exposure prophylaxis against HIV infection in health care workersP R Meylan, P Francioli, H Decrey, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistanceJ M Entenza, Y A Que, J Vouillamoz, et al.
Pageof 25